Back

A value-based analysis of the systematic use of dapagliflozin in patients with heart failure

29 August 2025 (15:15 - 16:30)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Public health and cardiovascular disease Health Economics ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Hector Bueno

National Centre for Cardiovascular Research (CNIC), Madrid (Spain)

12 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Mrs M. Caido (London, GB)
Abstract Slides Video
Presentation thumbnail
Doctor J. Fei (Beijing, CN)
Abstract
Presentation thumbnail
Doctor C. Huang (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Doctor R. Barbosa Sousa (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Public health and cardiovascular disease

The Event

Event poster

ESC Congress 2025

29 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Reducing the burden of advanced heart failure: a clinical and economical analysis of an intermittent Levosimendan programme
thumbnail
Congress Presentation
Carbon emission reduction associated with dapagliflozin compared to standard of care in the UK: translating the DAPA-HF and DELIVER trial findings to an environmental context
thumbnail
Congress Presentation
Reduction of heart failure hospitalization-related healthcare costs for transthyretin amyloid cardiomyopathy patients on treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources